🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 759757107 (prev. 879008209 )
- Market Cap
- Micro Cap · $6 Million
- Previous Symbol
- CLRX (changed 11/3/2015)
- Previous Name
- CollabRx, Inc.
Business: Tegal Corporation, since its founding in 1972, has been dedicated to the development and application of emerging technologies. Often on the forefront of major inventions, Tegal’s process and capital equipment know-how enabled the development and manufacturing of leading-edge devices – from early microprocessors to advanced memory and LEDs, as well as to newest filtering and sensing devices that are present in the most advanced smart phones. Most recently, in response to a challenging industry and financial environment, Tegal has set a new course to develop and support multiple efforts in the field of renewable energy and other diversified technologies. Through its recent investment in sequel Power, Tegal is engaged in the promotion of solar power plant development projects worldwide and other renewable energy projects. In addition, Tegal is actively evaluating opportunities for partnerships with other diversified technology-based companies in order to exploit our shared experience and to enhance our value as a public company. Tegal is headquartered in Petaluma, California.
Notes: November 2, 2015 -- CollabRx (CLRX), a clinical decision-support company delivering expert solutions in precision oncology, and Medytox Solutions, which owns and operates a diverse family of healthcare companies, including five clinical laboratories throughout the U.S., announced the completion of their merger. The new combined entity will be known as Rennova Health (RNVA) and will be listed on the NASDAQ stock exchange under the ticker symbol RNVA commencing Tuesday, November 3.CollabRx, Inc. (CLRX) will effect a change of name, a change of symbol, a reverse stock split, and CUSIP number change. The one for ten (1-10) reverse split of the outstanding common stock, the change of name and symbol to Rennova Health, Inc./RNVA and the CUSIP number change to 759757107 will become effective prior to the open of business on Tuesday, November 3, 2015
Company Contact
- CEO
- Thomas R. Mika
- CFO
- Christine Hergenrother
- Headquarters
- 2201 South McDowell Blvd., Petaluma, CA 94954
- Phone
- 707-763-5600
- Fax
- 707-765-9311
- Investor Relations
- Christine Hergenrother · 707-765-5600 · submission@tegal.com